Citius Pharma raises $3M in registered direct offering of 12M shares and 12M warrants

Citius Pharmaceuticals, Inc.

Offering consists of 12M common shares and warrants for 12M shares at combined $0.25; gross proceeds $3.0M.
Net proceeds approx. $2.7M after fees; intended for R&D, working capital, and general corporate purposes.
Warrants exercisable at $0.25 per share, immediately exercisable, expire in 5 years; cashless exercise if no effective registration.
Placement agent H.C. Wainwright receives 7% cash fee plus 840,000 placement agent warrants at $0.3125 per share.
Closing occurred November 18, 2024; offering made under existing effective shelf registration (File No. 333-277319).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.